BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 30198422)

  • 1. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
    Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer.
    Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2020 Jun; 42(6):1010428320924524. PubMed ID: 32515296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of G protein-coupled receptor 35 expression for predicting outcome in colon cancer.
    Ali H; AbdelMageed M; Olsson L; Israelsson A; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2019 Jun; 41(6):1010428319858885. PubMed ID: 31250711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.
    Gill S; Haince JF; Shi Q; Pavey ES; Beaudry G; Sargent DJ; Fradet Y
    Clin Colorectal Cancer; 2015 Jun; 14(2):99-105. PubMed ID: 25619805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome.
    AbdelMageed M; Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic expression of the chemokine CXCL17 in colon cancer cells.
    Ohlsson L; Hammarström ML; Lindmark G; Hammarström S; Sitohy B
    Br J Cancer; 2016 Mar; 114(6):697-703. PubMed ID: 26889977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761.
    D'Cunha J; Corfits AL; Herndon JE; Kern JA; Kohman LJ; Patterson GA; Kratzke RA; Maddaus MA
    J Thorac Cardiovasc Surg; 2002 Mar; 123(3):484-91; discussion 491. PubMed ID: 11882819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The myeloid cell biomarker EMR1 is ectopically expressed in colon cancer.
    Ali H; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2021; 43(1):209-223. PubMed ID: 34486997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of occult metastases in colon cancer.
    Merrie AE; van Rij AM; Dennett ER; Phillips LV; Yun K; McCall JL
    Dis Colon Rectum; 2003 Feb; 46(2):221-31. PubMed ID: 12576896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker.
    Nosotti M; Falleni M; Palleschi A; Pellegrini C; Alessi F; Bosari S; Santambrogio L
    Chest; 2005 Sep; 128(3):1539-44. PubMed ID: 16162755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of carcinoembryonic antigen mRNA in peritoneal lavage by the transcription-reverse transcription concerted method indicates poor prognosis in patients with stage II and III colon cancer.
    Murono K; Kazama S; Yamaguchi H; Kawai K; Ishihara S; Sunami E; Kitayama J; Satoh Y; Kurihara M; Yatomi Y; Watanabe T
    Surgery; 2015 Feb; 157(2):322-30. PubMed ID: 25311262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of cytokeratin 20 and mucin 2 mRNA as metastasis markers in regional lymph nodes of colon cancer patients investigated by quantitative RT-PCR.
    Nordgård O; Oltedal S; Kørner H; Aasprong OG; Tjensvoll K; Gilje B; Heikkilä R
    Int J Colorectal Dis; 2009 Mar; 24(3):261-8. PubMed ID: 19119477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: impact on staging and prognosis.
    Li J; Li ZN; Yu LC; Shi SB; Ge LP; Wu JR; Hu YM
    Clin Transl Oncol; 2013 Nov; 15(11):882-8. PubMed ID: 23404657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients.
    AbdelMageed M; Ismail HTH; Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.
    Ohlsson L; Israelsson A; Öberg Å; Palmqvist R; Stenlund H; Hammarström ML; Hammarström S; Lindmark G
    Int J Cancer; 2012 Apr; 130(8):1833-43. PubMed ID: 21618511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter study.
    Sargent DJ; Shi Q; Gill S; Louvet C; Everson RB; Kellner U; Clancy TE; Pipas JM; Resnick MB; Meyers MO; Wu TT; Huntsman D; Validire P; Farooq U; Pavey ES; Beaudry G; Haince JF; Fradet Y
    Clin Cancer Res; 2014 Aug; 20(16):4361-9. PubMed ID: 24919572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.
    Cagir B; Gelmann A; Park J; Fava T; Tankelevitch A; Bittner EW; Weaver EJ; Palazzo JP; Weinberg D; Fry RD; Waldman SA
    Ann Intern Med; 1999 Dec; 131(11):805-12. PubMed ID: 10610624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.
    Sargent DJ; Resnick MB; Meyers MO; Goldar-Najafi A; Clancy T; Gill S; Siemons GO; Shi Q; Bot BM; Wu TT; Beaudry G; Haince JF; Fradet Y
    Ann Surg Oncol; 2011 Nov; 18(12):3261-70. PubMed ID: 21533822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of occult tumor cells in lymph nodes from non-small cell lung cancer patients using reverse transcription-polymerase chain reaction for carcinoembryonic antigen mRNA with the evaluation of its sensitivity.
    Maeda J; Inoue M; Okumura M; Ohta M; Minami M; Shiono H; Shintani Y; Matsuda H; Matsuura N
    Lung Cancer; 2006 May; 52(2):235-40. PubMed ID: 16510209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid, quantitative reverse transcriptase-polymerase chain reaction: application to intraoperative molecular detection of occult metastases in esophageal cancer.
    Raja S; Luketich JD; Kelly LA; Gooding WE; Finkelstein SD; Godfrey TE
    J Thorac Cardiovasc Surg; 2002 Mar; 123(3):475-82; discussion 482-3. PubMed ID: 11882818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.